Toronto, Canada (PRWEB) May 21, 2013
As the R&D sector becomes increasingly competitive, there is a strong push within the industry to deliver better products, faster. Collaborations between Contract Development and Manufacturing Organizations and pharma companies often means turning big ideas into reality, within short time frames.
Microtablets, developed in collaboration with Sensidose AB and Recipharm, is one example of how effective outsourcing can bring products to market sooner. The partnership resulted in the development of a new dose automate delivery technology —slated to launch later this year— which can be customized to dispense medication according to individual requirement related to both dose amount and time.
In this webinar, keynote presenter Dr. Torkel Gren, Director at Recipharmm, will review how an effective collaboration between client and service provider can be achieved in outsourcing pharmaceutical development. The development of the microtablet, as well as how this concept can be used to develop new products of established active ingredients with a significantly improved therapeutic value, will be discussed.
A Q&A with the audience will follow the main presentation.
For more information about this event or to register, visit: http://xtalks.com/Innovative-Microtablet-Dosage-Form-Development.ashx.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn mo
Copyright©2012 Vocus, Inc.
All rights reserved